Latest news
RevMed, BeOne make clinical trial, Asia deal; MoonLake reports Phase 3 win - Endpoints NewsEndpoints News · Mon, 10 Aug 2026 15:33:00 GMTSobi, Innate sign $580M pact to propel lymphoma drug through Phase III - FirstWord PharmaFirstWord Pharma · Mon, 10 Aug 2026 15:22:30 GMTPhase 2 data: ABCL635 reduces frequency, severity of VMS symptoms - Contemporary OB/GYNContemporary OB/GYN · Mon, 10 Aug 2026 14:54:42 GMTSilence Therapeutics Announces Positive Phase 2 SANRECO Trial Outcomes for Divesiran in Polycythemia Vera - Kalkine MediaKalkine Media · Mon, 10 Aug 2026 14:00:27 GMTTenax sees 'clear path forward' for heart failure drug despite Phase III miss - FirstWord PharmaFirstWord Pharma · Mon, 10 Aug 2026 13:48:18 GMTDid Novo’s phase 3 flop kill the inflammation hypothesis in heart disease? - Pharma VoicePharma Voice · Mon, 10 Aug 2026 13:30:27 GMTArtelo Announces Enrollment of First Patient in a Phase 2 Clinical Trial Evaluating ART27.13 for Treatment of Glaucoma - The Manila TimesThe Manila Times · Mon, 10 Aug 2026 13:03:06 GMTArtelo Tests an Oral Cannabinoid for Glaucoma Eye Pressure - Stock TitanStock Titan · Mon, 10 Aug 2026 12:47:00 GMT